Page last updated: 2024-09-03

ro 46-2005 and ng-nitroarginine methyl ester

ro 46-2005 has been researched along with ng-nitroarginine methyl ester in 1 studies

Compound Research Comparison

Studies
(ro 46-2005)
Trials
(ro 46-2005)
Recent Studies (post-2010)
(ro 46-2005)
Studies
(ng-nitroarginine methyl ester)
Trials
(ng-nitroarginine methyl ester)
Recent Studies (post-2010) (ng-nitroarginine methyl ester)
260112,6401172,342

Protein Interaction Comparison

ProteinTaxonomyro 46-2005 (IC50)ng-nitroarginine methyl ester (IC50)
Neutrophil elastaseHomo sapiens (human)2.7
Nitric oxide synthase, endothelialHomo sapiens (human)2.1
Nitric oxide synthase, brainHomo sapiens (human)1.1167
Nitric oxide synthase, inducibleMus musculus (house mouse)2.6
Nitric oxide synthase, inducibleHomo sapiens (human)8
Collagenase 3Homo sapiens (human)2.7

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Breu, V; Clozel, M; Gray, GA; Löffler, BM1

Other Studies

1 other study(ies) available for ro 46-2005 and ng-nitroarginine methyl ester

ArticleYear
In vivo pharmacology of Ro 46-2005, the first synthetic nonpeptide endothelin receptor antagonist: implications for endothelin physiology.
    Journal of cardiovascular pharmacology, 1993, Volume: 22 Suppl 8

    Topics: Anesthesia; Animals; Arginine; Blood Pressure; Endothelin Receptor Antagonists; Endothelins; Heart Rate; In Vitro Techniques; Injections, Intravenous; Male; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyrimidines; Rats; Rats, Wistar; Sulfonamides

1993